Traders should monitor for follow-up filings or commentary, as coordinated C-suite selling may signal reduced confidence in near-term prospects, especially if not part of a pre-arranged plan. Compare against historical Form 4 patterns to assess whether this is routine or atypical.
GILD drugs
GILD drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 15 $139.60entry
- T+1 · 7mo ago −0.80%α −1.05% · $138.49
- T+5 · 7mo ago −4.83%α −6.47% · $132.85
- T+20 · 6mo ago −3.34%α −9.38% · $134.94
- T+60 · 4mo ago −3.41%α −10.80% · $134.84
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Gilead Sciences executives, the CFO and Chief Communications Officer, each sold 3,000 shares in open-market transactions on April 15, 2026, totaling $846,000. The sales represent a modest but notable insider selling cluster by C-suite executives, occurring within a single day.
Key Financial Metrics
Key Facts
- CFO Andrew D. Dickinson sold 3,000 shares for $422,880 in an open-market transaction.
- Chief Communications Officer Johanna Mercier sold 3,000 shares for $422,880 in an open-market transaction.
- Both sales occurred on April 15, 2026, at $140.96 per share.
- Total value of the cluster: $845,760.
Financial Impact
$845,760 in open-market sales by two C-suite executives
Risk Factors
- Perception of insider skepticism, particularly given participation by CFO
- Potential for negative market reaction if no public rationale is provided
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GILD-1776379349175 |
Track record
30 reports on GILD
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
- Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
- Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers